Table 2.
(A) Analyses of eye and skin pigmentation as factor in the mean refractive outcome, following a double dose of cyclopentolate 1% (C + C; N = 201) and one dose of cyclopentolate 1% and one dose of tropicamide 1% (C + T; N = 202); a linear mixed model approach with a between‐ and within‐subject design, with subjects with a light iris colour and light skin pigmentation receiving C + T as the reference group. Difference in mean spherical equivalent (SEQ) in dioptres is displayed. (B) Results after adding 47 dark‐irided subjects to the model
|
A Spherical equivalent Clustered groups Dark–Very Dark Intervention*Iris colour*Skin pigmentation |
N c |
Mean SEQ ± SD d |
Mean SEQ difference | SE | 95% CI | p | |
|---|---|---|---|---|---|---|---|
| Lower bound | Upper bound | ||||||
| C + Ca Dark*Dark | 44 | −1.96 | 0.32 | −2.60 | −1.33 | 0.000 | |
| C + Ca Dark*Medium | 36 | −1.16 | 0.34 | −1.83 | −0.48 | 0.001 | |
| C + Ca Dark*Light | 12 | −0.67 | 0.51 | −1.67 | +0.34 | 0.191 | |
| C + Ca Medium*Medium | 22 | −0.72 | 0.40 | −1.51 | +0.07 | 0.074 | |
| C + Ca Medium*Light | 35 | −0.17 | 0.35 | −0.85 | +0.51 | 0.623 | |
| C + Ca Light*Light | 52 | −0.12 | 0.31 | −0.73 | +0.49 | 0.702 | |
| C + Tb Dark*Dark | 44 | −1.55 | 0.32 | −2.18 | −0.91 | 0.000 | |
| C + Tb Dark*Medium | 46 | −0.90 | 0.32 | −1.53 | −0.27 | 0.005 | |
| C + Tb Dark*Light | 6 | +0.27 | 0.69 | −1.08 | +1.62 | 0.696 | |
| C + Tb Medium*Medium | 22 | −0.64 | 0.40 | −1.44 | +0.15 | 0.112 | |
| C + Tb Medium*Light | 28 | −0.17 | 0.37 | −0.90 | +0.56 | 0.639 | |
| C + Tb Light*Light | 56 | +3.10 ± 1.87 | 0 e | 0.00 | |||
|
B Spherical equivalent +47 Dark‐irided subjects Intervention*Iris colour*Skin pigmentation |
N c |
Mean SEQ ± SD d |
Mean SEQ difference | SE | 95% CI | p | |
|---|---|---|---|---|---|---|---|
| Lower bound | Upper bound | ||||||
| C + Ca Dark*Dark | 56 | −1.84 | 0.30 | −2.42 | −1.26 | 0.000 | |
| C + Ca Dark*Medium | 51 | −1.26 | 0.30 | −1.85 | −0.66 | 0.000 | |
| C + Ca Dark*Light | 32 | −0.74 | 0.34 | −1.41 | −0.06 | 0.032 | |
| C + Ca Medium*Medium | 22 | −0.72 | 0.39 | −1.49 | +0.06 | 0.069 | |
| C + Ca Medium*Light | 35 | −0.18 | 0.34 | −0.84 | +0.49 | 0.599 | |
| C + Ca Light*Light | 52 | −0.12 | 0.30 | −0.71 | +0.47 | 0.693 | |
| C + Tb Dark*Dark | 56 | −1.53 | 0.30 | −2.10 | −0.95 | 0.000 | |
| C + Tb Dark*Medium | 61 | −1.02 | 0.29 | −1.59 | −0.45 | 0.000 | |
| C + Tb Dark*Light | 26 | −0.55 | 0.37 | −1.27 | +0.17 | 0.131 | |
| C + Tb Medium*Medium | 22 | −0.64 | 0.39 | −1.42 | +0.13 | 0.103 | |
| C + Tb Medium*Light | 28 | −0.18 | 0.36 | −0.89 | +0.53 | 0.619 | |
| C + Tb Light*Light | 56 | +3.10 ± 1.87 | 0 e | 0 | |||
C + C: two drops of cyclopentolate 1%.
C + T: one drop of cyclopentolate 1% and one drop of tropicamide 1%.
Number of measurements.
SEQ ± SD: spherical equivalent and standard deviation in dioptres.
Reference group.